IRWD: Analysis & Opinions

  1. Forest Files Cariprazine NDA - Analyst Blog

    December 04, 2012
    Forest Laboratories, Inc., (FRX) and Gedeon Richter Plc. recently announced the submission of a new drug application ...
  2. EU Approval for Ironwood's Constella - Analyst Blog

    November 30, 2012
    The European Commission recently granted approval to Ironwood Pharmaceuticals Inc. (IRWD) and partner Almirall, ...
  3. Ironwood Pharma Beats on All Fronts - Analyst Blog

    October 18, 2012
    Ironwood Pharmaceuticals, Inc.'s (IRWD) third-quarter 2012 earnings of 42 cents per share compared favorably with ...
  4. CHMP Positive on Ironwood's Constella - Analyst Blog

    September 27, 2012
    The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently provided a ...
  5. FDA OK's Forest-Ironwood's Linzess - Analyst Blog

    August 31, 2012
    Forest Laboratories, Inc. (FRX) and Ironwood Pharmaceuticals, Inc. (IRWD) recently announced that they received US ...
  6. Lexapro Generics Hurt Forest Results - Analyst Blog

    July 17, 2012
    Forest Laboratories, Inc. (FRX) reported earnings per share of 28 cents in the first quarter of fiscal 2013, 3 cents ...
  7. IPO Market Slows Down With Market Correction

    February 10, 2010
    The initial public offering market has recently hit a few bumps, as investors become nervous about the overall stock ...
Marketplace
Trading Center